TIQ-15

CAS No. 1380336-17-3

TIQ-15( TIQ-15 | TIQ 15 | TIQ15 )

Catalog No. M11572 CAS No. 1380336-17-3

TIQ-15 is a potent and selective CXCR4 antagonist, inhibits attachment of X4 HIV-1IIIB virus in MAGI-CCR5/CXCR4 cells with IC50 of 3 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1053 Get Quote
50MG 2142 Get Quote
100MG 2790 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    TIQ-15
  • Note
    Research use only, not for human use.
  • Brief Description
    TIQ-15 is a potent and selective CXCR4 antagonist, inhibits attachment of X4 HIV-1IIIB virus in MAGI-CCR5/CXCR4 cells with IC50 of 3 nM.
  • Description
    TIQ-15 is a potent and selective CXCR4 antagonist, inhibits attachment of X4 HIV-1IIIB virus in MAGI-CCR5/CXCR4 cells with IC50 of 3 nM; inhibits calcium release in Chem-1 cells with IC50 of 3 nM, shows no cross-activity in a panel of chemokine receptor assays in both CXCR and CCR types.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    TIQ-15 | TIQ 15 | TIQ15
  • Pathway
    GPCR/G Protein
  • Target
    Chemokine Receptor
  • Recptor
    Chemokine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1380336-17-3
  • Formula Weight
    364.537
  • Molecular Formula
    C23H32N4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NCCCCN(C[C@H]1CC2=C(C=CC=C2)CN1)[C@@H]3C4=NC=CC=C4CCC3
  • Chemical Name
    N1-(((R)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-N1-((S)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Truax VM, et al. ACS Med Chem Lett. 2013 Sep 5;4(11):1025-30. 2. Yesim A. Tahirovic, et al. ACS Med. Chem. Lett., 2018, 9 (5), pp 446-451.
molnova catalog
related products
  • GW-766994 R-form

    GW-766994 (GW766994) is a potent, selective, orally available CCR3 antagonist with pKi of 7.86 for inhibiting eotaxin-induced eosinophil chemotaxis in vitro assays.

  • CCR6 inhibitor 35

    CCR6 inhibitor 35 is a potent and selective CCR6 inhibitor with IC50 of 6.0 nM (hCCR6).

  • SB 265610

    A potent, selective, reversible CXCR2 antagonist with with Kd of 3.48 nM.